ACTRN12615001017516已完成1 期
A Phase I/IIa Study of the Efficacy and Safety of ASN-002 Alone and in Combination with 5-Fluorouracil (5-FU) in Adult Patients with Low-Risk Nodular Basal Cell Carcinoma
Ascend Biopharmaceutical Ltd.0 个研究点目标入组 16 人开始时间: 2015年9月29日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 16
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •1.Low risk nodular basal cell carcinoma
- •2.Biopsy of any other skin tumor
- •3.Willingness to have injection therapy followed by surgery
- •4.Written informed consent
排除标准
- •1.No or only minimal symptoms
- •2.Known or suspected metastatic disease.
- •3.Pregnant or Lactating females
- •4.Clinically active or uncontrolled skin disease
- •5.Immunocompromised or receiving immunomodulating agent
- •6.treatment with psoralen plus UVA or UVB therapy within 6 months
- •7.Any serious or active medical or psychiatric illness
- •8.Recreational or therapeutic drug or alcohol use
- •9.Taking any investigational product within 1 month of first dose of ASN-002.
研究者
相似试验
已完成
1 期
A phase I/II study for the safety and efficacy of Panitumumab in combination with TAS-102 for patients with RAS wild-type metastatic colorectal cancer refractory to standard chemotherapyunresectable advanced colorectal cancerJPRN-UMIN000019876Takeda Pharmaceutical Company Limited52
进行中（未招募）
不适用
A phase I/II study of the efficacy and safety of an intensified schedule of Azacitidine (Vidaza®) in intermediate-2 and high risk MDS patients - GFM-Aza intensifEUCTR2010-020341-27-FRGroupe Francophone des Myélodysplasies
进行中（未招募）
1 期
ot availableStaphylococcus aereus BacteremiaMedDRA version: 19.1Level: LLTClassification code 10058887Term: Staphylococcus aureus bacteremiaSystem Organ Class: 100000004862EUCTR2015-003510-25-DEXBiotech USA, Inc.52
招募中
3 期
A Phase 1/2/3 Study of the Safety and Efficacy of a Single Dose of Autologous CRISPR-Cas9 Modified CD34+ Human Hematopoietic Stem and Progenitor Cells (hHSPCs) in subjects with Transfusion-Dependent β-Thalassemia2024-516894-57-00Vertex Pharmaceuticals Inc.5
招募中
2 期
Exploratory Study of StrataXRT for Radiation Dermatitis in Breast Cancer Patients with Postoperative Radiation TherapyD001943Breast CancerJPRN-jRCT1032230451Ogita Mami50